{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:55:55Z","timestamp":1758124555680},"reference-count":57,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jpsychires.2010.02.005","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T06:04:41Z","timestamp":1271052281000},"page":"921-929","source":"Crossref","is-referenced-by-count":6,"title":["Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting"],"prefix":"10.1016","volume":"44","author":[{"given":"Terence A.","family":"Ketter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"John O.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Hoblyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne A.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Y.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenifer L.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy K.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie C.","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2010.02.005_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2007.02.004","article-title":"Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder","author":"Adler","year":"2007","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.jpsychires.2010.02.005_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib3","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.08m04629","article-title":"Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study","volume":"70","author":"Bauer","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2010.02.005_bib7","first-page":"111","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"Journal of Clinical"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":"Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial","volume":"71","author":"Bowden","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2010.02.005_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2010.02.005_bib9","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.08m04592","article-title":"Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study","volume":"70","author":"Cutler","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.02.005_bib11","first-page":"72","article-title":"Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder","volume":"40","author":"Dennehy","year":"2007","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib12","article-title":"Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study","author":"Goldberg","year":"2007","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.02.005_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v65n0321","article-title":"A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder","volume":"65","author":"Goodwin","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2010.02.005_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.v66n1001","article-title":"Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"66","author":"Grant","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2010.02.005_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib16","series-title":"Assessing medical technologies","author":"Institute of Medicine","year":"1985"},{"issue":"6","key":"10.1016\/j.jpsychires.2010.02.005_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.02.005_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2010.02.005_bib20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2010.02.005_bib24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4088\/JCP.v63n0210","article-title":"Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature","volume":"63","author":"Ketter","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2010.02.005_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpsychires.2008.02.007","article-title":"Effectiveness of lamotrigine in bipolar disorder in a clinical setting","volume":"43","author":"Ketter","year":"2009","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib22","series-title":"Handbook of diagnosis and treatment of bipolar disorder","author":"Ketter","year":"2010"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2010.02.005_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4088\/JCP.v63n0206","article-title":"Demographic and clinical characteristics of individuals in a bipolar disorder case registry","volume":"63","author":"Kupfer","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2010.02.005_bib27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib28","unstructured":"Macfadden W, Adler CM, Turner N, Turkoz I, Haskins JT, Alphs L. Long-acting risperidone adjunctive to standard treatment in patients with bipolar disorder who are experiencing mood symptoms. In: Eighth international conference on bipolar disorder, Pittsburgh, June 25\u201327, 2009; 2009."},{"issue":"5","key":"10.1016\/j.jpsychires.2010.02.005_bib29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1176\/appi.ajp.162.5.836","article-title":"The case for practical clinical trials in psychiatry","volume":"162","author":"March","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2010.02.005_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania-a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"European Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2010.02.005_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disorders"},{"issue":"5","key":"10.1016\/j.jpsychires.2010.02.005_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2010.02.005_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","article-title":"Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone","volume":"163","author":"Nierenberg","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial","volume":"25","author":"Potkin","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib35","unstructured":"Quiroz JA, Yatham LN, Palumbo JM, Karcher K, Kushner S, Kusumakar V. Randomized, placebo-controlled, long-term study of risperidone long-acting injectable in relapse prevention in bipolar I disorder patients. In: Eighth international conference on bipolar disorder, Pittsburgh, June 25\u201327, 2009; 2009."},{"issue":"19","key":"10.1016\/j.jpsychires.2010.02.005_bib36","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.264.19.2511","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study","volume":"264","author":"Regier","year":"1990","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1016\/j.jpsychires.2010.02.005_bib39","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2010.02.005_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1399-5618.2002.01195.x","article-title":"A clinical monitoring form for mood disorders","volume":"4","author":"Sachs","year":"2002","journal-title":"Bipolar Disorders"},{"issue":"11","key":"10.1016\/j.jpsychires.2010.02.005_bib42","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","article-title":"Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"53","author":"Sachs","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.02.005_bib37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disorders"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"Journal of Psychopharmacology"},{"issue":"17","key":"10.1016\/j.jpsychires.2010.02.005_bib41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jpsychires.2010.02.005_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","article-title":"Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol","volume":"15","author":"Smulevich","year":"2005","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2010.02.005_bib44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2010.02.005_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.jpsychires.2010.02.005_bib49","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2010.02.005_bib48","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2010.02.005_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychires.2010.02.005_bib50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2010.02.005_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2010.02.005_bib51","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1185\/030079905X46340","article-title":"Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies","volume":"21","author":"Vieta","year":"2005","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1016\/j.jpsychires.2010.02.005_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"10","key":"10.1016\/j.jpsychires.2010.02.005_bib53","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib54","unstructured":"Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B. Quetiapine or lithium versus placebo for maintenance treatment of bipolar I disorder after stabilization on quetiapine. In: Eighth international conference on bipolar disorder, Pittsburgh, June 25\u201327, 2009; 2009."},{"issue":"1","key":"10.1016\/j.jpsychires.2010.02.005_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/ajp.156.1.5","article-title":"Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research","volume":"156","author":"Wells","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.02.005_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial","volume":"182","author":"Yatham","year":"2003","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2010.02.005_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania","volume":"24","author":"Yatham","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:26:36Z","timestamp":1685561196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395610000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":57,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0022395610000464"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2010.02.005","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}